David Christian Hanley

Title: The Innovative Contributions of David Christian Hanley

Introduction

David Christian Hanley is a notable inventor based in Brookfield, CT (US). He has made significant contributions to the field of medicine, particularly in the development of treatment regimens that utilize dexmedetomidine. With a total of 15 patents to his name, Hanley's work has the potential to impact the treatment of various neuropsychiatric conditions.

Latest Patents

One of Hanley's latest patents focuses on non-sedating dexmedetomidine treatment regimens. This patent discloses methods of administering relatively high doses of dexmedetomidine or a pharmaceutically acceptable salt thereof to a human subject, without inducing significant sedation. The methods are particularly suitable for treating agitation associated with neurodegenerative and neuropsychiatric diseases such as schizophrenia, bipolar disorder, dementia, depression, and delirium.

Career Highlights

Throughout his career, David Hanley has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bioxcel Therapeutics, Inc. and Arx Limited. His work in these organizations has allowed him to further develop his innovative ideas and contribute to advancements in medical treatments.

Collaborations

Hanley has collaborated with several professionals in his field, including Frank Yocca and Chetan Dalpatbhai Lathia. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.

Conclusion

David Christian Hanley is a distinguished inventor whose work in developing non-sedating treatment regimens has the potential to transform the management of neuropsychiatric conditions. His contributions to the field are noteworthy and reflect his commitment to innovation in medicine.